Brilliant deep dive. The idea that models dunno need mechanistic understanding but can learn latent morphogenesis rules directly from developmental atlases is kinda transformative. I spent months trying to explain why simple cell injections fail to stakeholders, and the coevolution of ECM with cell populations finally clicked the concept for them. Process defensibility over patent cliffs also changes biotech economics fundamentaly.
Brilliant deep dive. The idea that models dunno need mechanistic understanding but can learn latent morphogenesis rules directly from developmental atlases is kinda transformative. I spent months trying to explain why simple cell injections fail to stakeholders, and the coevolution of ECM with cell populations finally clicked the concept for them. Process defensibility over patent cliffs also changes biotech economics fundamentaly.